HansBiomed Corporation (KOSDAQ:042520)

Revenue by Product

Financials in millions KRW. Fiscal year is October - September.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006	FY 2005
Period Ending	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016	Sep 30, 2015	Sep 30, 2014	Sep 30, 2013	Sep 30, 2012	Sep 30, 2011	Sep 30, 2010	Sep 30, 2009	Sep 30, 2008	Sep 30, 2007	Sep 30, 2006	Sep 30, 2005
Human Tissue	39.52B
Human Tissue Growth	6.24%
Medical Devices	36.82B
Medical Devices Growth	-1.58%
Other	4.80B
Other Growth	40.20%
Other	4.80B
Other Growth	40.20%

Revenue by Geography

Financials in millions KRW. Fiscal year is October - September.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006	FY 2005
Period Ending	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016	Sep 30, 2015	Sep 30, 2014	Sep 30, 2013	Sep 30, 2012	Sep 30, 2011	Sep 30, 2010	Sep 30, 2009	Sep 30, 2008	Sep 30, 2007	Sep 30, 2006	Sep 30, 2005
Other	787.07M
Other Growth	9.07%
South Korea	43.47B
South Korea Growth	5.89%
North America	19.72B
North America Growth	-0.67%
Asia	10.53B
Asia Growth	20.57%
South America	4.91B
South America Growth	-9.33%
Europe	1.72B
Europe Growth	-23.79%
Other	787.07M
Other Growth	9.07%